VII-31 (100 nM, 200 nM; 48 hours) inhibits the cell viability of gastric cell line MGC803 with an IC50 of 0.09±0.01 μM. VII-31 also inhibits the cell viability of MCF-7 and PC-3 with IC50s of 0.10±0.006 and 1.15±0.28μM , respectively.
VII-31 (50-150 nM; 24 hours) arrests MGC803 cells cycle in G2/M phase.
VII-31 (50-150 nM; 48 hours) induces apoptosis via intrinsic and extrinsic pathways.
VII-31 (50-150 nM; 24 hours) activates NEDDylation in MGC803 cells.
VII-31 (50-150 nM; 48 hours) up-regulates pro-apoptotic proteins FADD, Fasl, PIDD, Bax, Bad; while down-regulates anti-apoptotic proteins Bcl-xL, Bcl-2, XIAP, c-IAP1.
Cell Viability Assay
| Cell Line: |
Gastric cancer MGC803 cells |
| Concentration: |
100, 200 nM |
| Incubation Time: |
48 hours |
| Result: |
Inhibited the cell viability in dose-depend manner. |
Cell Cycle Analysis
| Cell Line: |
MGC803 cells |
| Concentration: |
50, 100, 150 nM |
| Incubation Time: |
24 hours |
| Result: |
Arrested cells in G2/M phase, and a clear sub-G1 peak was observed in the high dose group. |
Apoptosis Analysis
| Cell Line: |
MGC803 cells |
| Concentration: |
50, 75, 100, and 150 nM |
| Incubation Time: |
48 hours |
| Result: |
High dose (150 nM) treatment significantly elevated the early and late apoptosis rate to 92.8% from 4.8%. |
Western Blot Analysis
| Cell Line: |
MGC803 cells |
| Concentration: |
50, 100, 150 nM |
| Incubation Time: |
24 hours |
| Result: |
Resulted in NEDDylation activation of MGC803 cells, the NEDDylation of 3 important proteins NAE1, Ubc12 and CUL1 has been activated. |